News
COMUNICATO STAMPA: Costituita oggi l’associazione Life Sciences CC che guiderà il terzo Centro di Competenza dello Switzerland Innovation Park Ticino
HAS Healthcare Advanced Synthesis SA (Biasca, Switzerland) achieves Carbon Neutrality
TIBIO – Azienda ticinese selezionata tra gli attori chiave nel mercato mondiale dei prodotti chimici basati sulle biotecnologie
Helsinn announces publication of new data evaluating impact of NEPA (netupitant/palonosetron) on hospital costs
Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets
Helsinn closes financing agreement with Oberland Capital
Helsinn announces the appointment of Dr Melanie Rolli as Group Chief Executive Officer
Helsinn closes financing agreement with Oberland Capital

Linkedin